Actinogen Medical Limited (ATGGF)

Actinogen Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 24, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	46	111	48	62	162	17
Market Cap Growth	129.54%	129.54%	-21.84%	-61.78%	854.59%	116.05%
Enterprise Value	40	103	39	47	152	11
Last Close Price	0.02	0.01	0.01	0.02	0.02	0.04
PS Ratio	16.75	16.75	14.86	24.66	108.80	6.98
PB Ratio	8.45	8.45	5.42	4.13	12.37	2.26
P/TBV Ratio	9.45	9.45	6.60	4.72	14.97	3.26
EV/Sales Ratio	6.51	15.60	11.93	18.61	102.47	4.70
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.01	0.04
Asset Turnover	0.54	0.54	0.25	0.17	0.13	0.25
Quick Ratio	13.83	13.83	6.98	13.73	19.87	10.36
Current Ratio	13.91	13.91	7.04	13.80	19.99	10.98
Return on Equity (ROE)	-78.81%	-78.81%	-61.18%	-48.46%	-27.62%	-40.15%
Return on Assets (ROA)	-45.37%	-45.37%	-35.65%	-28.59%	-16.16%	-23.95%
Return on Capital (ROIC)	-49.45%	-49.45%	-38.79%	-30.09%	-16.91%	-25.03%
Earnings Yield	-7.84%	-7.84%	-14.80%	-10.58%	-1.81%	-21.71%
FCF Yield	-10.19%	-10.19%	-12.02%	-10.60%	-0.80%	-11.72%
Buyback Yield / Dilution	-20.69%	-20.69%	-4.92%	-22.20%	-25.69%	-1.43%
Total Shareholder Return	-20.69%	-20.69%	-4.92%	-22.20%	-25.69%	-1.43%

Source: S&P Capital IQ. Standard template. Financial Sources.